tailieunhanh - The off-label use of targeted therapies in sarcomas: The OUTC’S program

Few targeted therapies (TTs) are registered for sarcoma treatment despite numerous phase II studies and yet there are potential treatment options for patients after standard treatment escape. The French Sarcoma Group - Bone Tumor Study Group (GSF-GETO) created a national registry to evaluate the outcome of patients treated with off-label TTs. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN